Teh L C, Froger M
Department of Blood Products Development, Auckland Hospital, New Zealand.
J Chromatogr. 1992 Nov 6;582(1-2):65-70. doi: 10.1016/0378-4347(92)80303-8.
This report is an analysis of the parameters involved in the preparation of a C1-esterase inhibitor concentrate. We investigated ways to improve the purification by finding the optimal pH, ionic strength, and quantity of chromatographic media to use at each step. The optimisation of the process gave a greater than two-fold increase in both yield and purity over published methods. The product retained more than 50% activity upon dry heat-treatment at 80 degrees C for 72 h, and the yield of the heat-treated product was 180 I.U./kg of plasma.
本报告是对C1酯酶抑制剂浓缩物制备过程中涉及的参数进行的分析。我们通过寻找每个步骤的最佳pH值、离子强度和色谱介质用量来研究改进纯化方法。该工艺的优化使产量和纯度比已发表的方法提高了两倍多。该产品在80℃干热处理72小时后仍保留超过50%的活性,热处理产品的产量为每千克血浆180国际单位。